Fondaparinux Sodium Injection, Solution
Product Images NDC 70710-1515

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Fondaparinux Sodium (NDC 70710-1515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (01)

Chemical structure of fondaparinux sodium showing its molecular arrangement with sodium ions and multiple sugar rings connected by oxygen atoms.*

FDA Label Image

1406

Packaging label for Fondaparinux Sodium Injection USP, 2.5 mg/0.5 mL, single-dose prefilled syringes for subcutaneous use. The label includes manufacturer and distributor information, barcode, and instructions indicating the presence of an automatic needle protection system. Labeler is Zydus Pharmaceuticals (USA) Inc.*

FDA Label Image

1409

Packaging label for Fondaparinux Sodium Injection USP, 2.5 mg/0.5 mL, subcutaneous injection. The label indicates it contains 2 single dose prefilled syringes with an automatic needle protection system. Distributed by Zydus Pharmaceuticals (USA) Inc. and manufactured by Italfarmaco S.p.A. The label includes storage instructions, barcode, lot, expiry, and serial number information.*

FDA Label Image

1506

Packaging label for Fondaparinux Sodium Injection USP, 5 mg/0.4 mL solution for subcutaneous injection. The label indicates single-dose prefilled syringes with an automatic needle protection system. It includes storage information, manufacturer details (Italfarmaco S.p.A.), and distributor Zydus Pharmaceuticals (USA) Inc. The package contains 10 prefilled syringes.*

FDA Label Image

1509

Fondaparinux Sodium Injection USP 5 mg/0.4 mL boxed packaging label, containing 2 single-dose prefilled syringes for subcutaneous injection. The label shows product strength, dosage form, quantity (2 x 0.4 mL), and notes the automatic needle protection system. Distributed by Zydus Pharmaceuticals (USA) Inc., manufactured by Italfarmaco S.p.A., with pharmacy dispensing instructions and storage information.*

FDA Label Image

1606

Packaging label for Fondaparinux Sodium Injection USP, 7.5 mg / 0.6 mL, a subcutaneous injection provided as single dose prefilled syringes with an automatic needle protection system. The box prominently features the product name, strength, and dosage form, and states it contains 10 single dose prefilled syringes. Distributed by Zydus Pharmaceuticals (USA) Inc., the label includes storage instructions and barcode details.*

FDA Label Image

1609

Packaging label for Fondaparinux Sodium Injection USP 7.5 mg/0.6 mL, a subcutaneous injection. The label indicates it contains 2 single-dose prefilled syringes with automatic needle protection. Manufactured by Italfarmaco S.p.A. and distributed by Zydus Pharmaceuticals (USA) Inc. The label includes storage instructions, contents, and a pharmacist dispensing note. The design features blue, pink, and purple colors with dosage details prominently displayed.*

FDA Label Image

1706

Packaging label for Fondaparinux Sodium Injection USP, 10 mg / 0.8 mL, subcutaneous injection. The box indicates single dose prefilled syringes with an automatic needle protection system. Distributed by Zydus Pharmaceuticals (USA) Inc., the label includes usage instructions and storage information. The package contains 10 single dose prefilled syringes.*

FDA Label Image

1709

The packaging label for Fondaparinux Sodium Injection USP, 10 mg/0.8 mL, a subcutaneous injection solution. The label indicates two single-dose prefilled syringes per package with an automatic needle protection system. It is manufactured by Italfarmaco S.p.A. and distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ. The label includes storage instructions, contents, and a barcode.*

FDA Label Image

12 (Figure12)

Two-panel instructional illustration showing administration of fondaparinux sodium injection. The first panel depicts removal of the syringe cap before injection. The second panel shows subcutaneous injection being administered into the abdominal area, demonstrating proper injection technique.*

FDA Label Image

34 (Figure34)

Two photographic illustrations showing the proper technique for administering a subcutaneous injection. A healthcare professional wearing gloves inserts a syringe needle into the abdominal area of a patient to deliver the injection.*

FDA Label Image

5 (Figure5)

An instructional photograph showing a hand holding a syringe filled with a liquid medication. A black arrow points to a part of the syringe near the needle end, indicating a specific step or focus in the injection preparation or administration process.*

FDA Label Image

Selfinj1 (Selfinj1)

Instructions for self-administration of fondaparinux sodium injection show labeled syringe parts including rigid needle guard, plunger, finger-grip, and security sleeve. Pictures illustrate the syringe before and after use. Additional photos demonstrate the recommended patient position and injection site on the lower abdomen for subcutaneous injection.*

FDA Label Image

Selfinj2 (Selfinj2)

Instructional image showing steps for subcutaneous injection. Figure B illustrates pulling the needle shield straight off the syringe. Figure C depicts gently pinching skin to make a fold, held between thumb and forefinger. Figure D shows inserting the needle at a 90-degree angle into the skin fold for injection.*

FDA Label Image

Selfinj3 (Selfinj3)

Instructional images illustrating steps for subcutaneous injection of fondaparinux sodium. One image shows injecting medicine by pressing the syringe plunger fully (Figure E). Another shows activating the syringe safety system by pushing the plunger rod to cover the needle with a protective sleeve accompanied by an audible click (Figure F). Additional text notes safety precautions for activating the system after injection.*

FDA Label Image

Selfinj4 (Selfinj4)

A text panel titled 'Disposing of used - fondaparinux sodium injection needles and syringes:' providing instructions on proper disposal of used fondaparinux sodium injection needles and syringes. It advises using an FDA-cleared sharps disposal container and outlines alternative household container criteria if no FDA-cleared container is available. Additional guidance includes following community disposal guidelines and avoiding disposal or recycling of sharps containers in household trash unless permitted. The panel also includes manufacturer and distributor information for italafmaco S.p.A. and Zydus Pharmaceuticals (USA) Inc., respectively.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.